ORAMED PHARM INC
ORAMED PHARM INC Web Site
Back to Directory   


 
  Recent News
TITLE DATE
Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA) 25-Oct-2011
Oramed Pharmaceuticals Announces Successful Phase 1 Clinical Trial Results for EnteraBio 27-Sep-2011
Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011 15-Sep-2011
Oramed Pharmaceuticals to Present at Rodman & Renshaw 13th Annual Global Investment Conference 8-Sep-2011
Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board 22-Jun-2011
Oramed Pharmaceuticals to Present at The 1st Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CHODy), China 2011 18-May-2011
Oramed Pharmaceuticals to Present at the 10th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2011 11-May-2011
Oramed Successfully Completes Toxicity Study for ORMD-0801 23-Mar-2011
Oramed Pharmaceuticals Announces Completion of $3.4 Million Private Placement Round 9-Mar-2011
Oramed Pharmaceuticals Sells its Stake in Entera Bio for $1.15 Million; Buyer Also to Invest $250,000 in Oramed 28-Feb-2011
Oramed Chosen to Lecture at the Fourth International Conference on Advanced Technologies and Treatments for Diabetes in London, England 15-Feb-2011
Oramed Pharmaceuticals Announces Publication in the Journal of Diabetes Science and Technology 1-Dec-2010
Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD 15-Nov-2010
Oramed Pharmaceuticals to Present Results of an Oral Insulin Administration Study at the Tenth Annual Meeting of the Diabetes Technology Society (November 11-13, 2010; Bethesda, MD) 26-Oct-2010
Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules 7-Jul-2010
Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 28-Jun-2010
Oramed Pharmaceuticals was Chosen to Present Two Abstracts at the 70th Scientific Sessions of the American Diabetes Association in Orlando, FL, June 25-29, 2010 15-Jun-2010
Oramed Pharmaceuticals to Present at the 9th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2010 8-Jun-2010
Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 2-Jun-2010
Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism 26-May-2010
Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors 18-May-2010
Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 6-May-2010
Oramed Announces Completion of Pivotal Phase 2b Clinical Trials of it's Oral Insulin Capsule, ORMD-0801 for Type 2 Diabetes 25-Mar-2010
Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 16-Feb-2010
Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland 10-Feb-2010
Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801 19-Jan-2010
Oramed Pharmaceuticals Announces Filing of Two Registration Statements 11-Jan-2010
Oramed Pharmaceuticals to Present at OneMedPlace Finance Forum in San Francisco, California 5-Jan-2010
Oramed's Dr Roy Eldor was Chosen to Lecture at the First International Conference Held by the Bildirici Center for Diabetes Care Research in Israel. 21-Dec-2009
Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA) 27-Oct-2009
Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA) 20-Oct-2009
Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog 9-Sep-2009
Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference 3-Sep-2009
Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award 25-Aug-2009
Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England 18-Aug-2009
Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist 4-Aug-2009
Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 21-Jul-2009
Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009 10-Jun-2009
Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule 5-May-2009
Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA) 25-Mar-2009
Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 4-Feb-2009
Oramed Pharmaceuticals Presents Results of Oral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs 14-Nov-2008
Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland) 4-Nov-2008
Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository 23-Oct-2008
Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform 16-Sep-2008
Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801 9-Sep-2008
Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 18-Aug-2008
Oramed Insulin Pill Safe, Lowers Blood Sugar, Early Study Shows 6-Aug-2008
Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule 6-Aug-2008
Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials 31-Jul-2008
Is Oral Insulin Pill On Horizon? 31-Jul-2008
Oramed Pharmaceuticals Appoints Dr. Harold Jacob to its Board of 28-Jul-2008
Oramed Pharmaceuticals Raises $5 Million Through a Private 15-Jul-2008
Nobel Prize Winner Professor Avram Hershko Named to Oramed Pharmaceuticals Scientific Advisory Board 10-Jul-2008
Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco) 4-Jun-2008
Israel's Prestigious President's Conference to Feature Oramed Pharmaceuticals' Revolutionary Oral Insulin Capsule 6-May-2008
Oramed Pharmaceuticals Partners with OnQ Consulting for Phase 2B Trials on Its Oral Insulin Capsules 17-Apr-2008
Oramed Pharmaceuticals Commences Phase 2A Clinical Trials in Israel 14-Apr-2008
Oramed Pharmaceuticals Granted Approval to Conduct Phase 2A Trials of Its Oral Insulin Capsule 18-Mar-2008
Oramed Pharmaceuticals Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule 11-Mar-2008
Oramed Pharmaceuticals Teams up with OnQ Consulting 30-Jan-2008
Oramed Pharmaceuticals Commences Phase 1B Clinical Trials 22-Jan-2008
Insulin News That's Easy To Swallow 17-Jan-2008
Oramed Pharmaceuticals Successfully Completes Animal Studies for Phase 1B Clinical Trials Of Its Oral Insulin Capsule 15-Nov-2007
Oramed's CEO to Present at Rodman & Renshaw's Ninth Annual Healthcare Conference On November 6, 2007 2-Nov-2007
Oramed Pharmaceuticals Successfully Completes Phase 1A Trials 14-Aug-2007
Oramed Pharmaceuticals Completes $2 million in Financing 6-Aug-2007
Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials 8-May-2007
Shazamstocks.com Announces Profile Launch of Oramed Pharmaceuticals, Inc. 3-May-2007
Oramed Pharmaceuticals Expands Product Line With the Addition of Two New Provisional Patents in the Intellectual Property Portfolio 1-May-2007
Exclusive Interview With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.Wallst.Net 18-Apr-2007
AllPennyStocks.com Releases a Special Report On Oramed Pharmaceuticals Inc. 11-Apr-2007
Oramed Pharmaceuticals Begins Additions to an Advisory Board 10-Apr-2007
Oramed Pharmaceuticals Rated 'Speculative Buy,' Target Price $1.20 by Beacon Equity Research 21-Mar-2007
Oramed Pharmaceuticals Announces Maiden Year Progress Report 13-Mar-2007
Oramed Pharmaceuticals Announces the Completion of its World Renowned Scientific Board 22-Feb-2007
Oramed Pharmaceuticals Inc. Adds Another Accomplished Member to Its Scientific Board 21-Feb-2007
Oramed Pharmaceuticals Announces the Expansion of Its Scientific Board With a Prominent American Figure in Diabetes Research 31-Jan-2007
Oramed Further Enhances World Renowned Scientific Board of Directors 16-Jan-2007
Oramed Pharmaceutical, Inc. Adds to its Scientific Advisory Board 9-Jan-2007
Oramed Pharmaceuticals Discusses Benefits of Oral Insulin Capsule Versus Insulin Inhaler 14-Dec-2006
Companies Present at Yale Club in New York City -- EQUITIES Announces Discovery Day Conference XIII 27-Nov-2006
Oramed Pharmaceuticals Signs Manufacturing Agreement for Oral Insulin Pill 2-Nov-2006
Oramed Pharmaceuticals Technology Patented with WIPO 13-Sep-2006
Oramed Pharmaceuticals Obtains Dual Listing on Frankfurt Stock Exchange 2-Aug-2006
Oramed Pharmaceuticals Receives MOH and IRB Approval to Begin Phase 1 Human Trials for 11-Jul-2006
Oral Insulin Pill Could Bring Relief to Millions 20-Jun-2006
Exciting Growth Companies to Present at EQUITIES Summer Conference 2006 on June 16, at 13-Jun-2006
Oramed Pharmaceuticals combats diabetes with oral insulin 12-Jun-2006
Integrated Security Technologies Complete Acquisition of Oral Insulin Patent Application 13-Mar-2006
Insulin pill offers hope for diabetes 5-Jul-2005